Status:
RECRUITING
Impact of Mindfulness Intervention on Quality of Life in Patients With Drug-resistant Epilepsy.
Lead Sponsor:
University Hospital, Grenoble
Conditions:
Drug Resistant Epilepsy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study evaluates a mindfulness intervention in patients with drug resistant epilepsy. Half of participants will follow a mindfulness programme, while the other half will follow a self management ...
Detailed Description
Drug-resistant epilepsy is associated with an alteration of the quality of life mainly related to psychiatric comorbidities (anxiety and depression). The management of these comorbidities is therefore...
Eligibility Criteria
Inclusion
- Drug resistant epilepsy according to the criteria of the International League Against Epilepsy (ILAE)
- Stable therapy for at least 3 months
- No planned surgery
- Patient affiliated to social security insurance or beneficiary of social security insurance.
- Signed consent
Exclusion
- Patient who has previously had or regularly practicing mindfulness
- Patient with psychogenic non-epileptic seizures
- Pregnant woman, breastfeeding mother, person deprived of liberty by judicial or administrative decision, person subject to legal protection
- Patient with relationship disorders related to psychosis
- Patients who are unable or unwilling to work as a group or person unable to understand the topics discussed during session.
Key Trial Info
Start Date :
January 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 20 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04126369
Start Date
January 20 2020
End Date
September 20 2027
Last Update
May 8 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Epileptology Department of The Grenoble University Hospital
Grenoble, France
2
Epileptology Department of the Lyon University Hospital
Lyon, France
3
La Teppe medical centre
Tain-l'Hermitage, France